Angelman's syndrome' (sometimes known as the ' happy puppet' syndrome) is characterised by mental retardation, profound speech delay, jerky voluntary movement, a happy disposition with paroxysms of laughter, tongue thrusting, and a characteristic facial appearance. The gradual evolution and subtlety of the facial dysmorphism, which includes a prominent jaw, wide mouth, and midfacial hypoplasia, has complicated the clinical diagnosis of patients in the past. Seizures are very common and the syndrome is associated with an unusual electroencephalogram (EEG) which is now recognised as -a key diagnostic feature.2
The description of just two questionable affected sib pairs and one definite sib pair3 in reports up to 1982 led Williams and Frias4 to conclude in their review that there was little evidence of Mendelian inheritance in the group as a whole. Since that time,
Fisher et aP reported a sib pair and, in reviewing the families of 38 previously reported cases, concluded that a 5% sib recurrence risk would be appropriate for genetic counselling. Baraitser et a16 described seven cases from three families and in the title of their report asked whether Angelman' s syndrome might be an autosomal recessive condition after all.
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Willems et al, in reporting an affected sib pair, concluded that the sib recurrence risk was overall 1 to 2%.
We report the association of Angelman's syndrome and chromosomal deletions within 15qll-13, which not only provisionally maps the gene locus to this region, but is the first step towards elucidating the mechanism of inheritance in this condition.
Subjects and methods
In recalling families known to Angelman' s syndrome patients in whom chromosomes had been examined, but with no particular attention being paid to chromosome 15. In nine, the initial report was 'normal karyotype', while in patient 3, whose clinical diagnosis coincided with the start of this study, the deletion within 15qll-13 was noted on the initial report. The slides of all 12 chromosome preparations were analysed by one of us (JvdB) who was not involved in the initial reports. This allowed a direct comparison of the breakpoints and represented an additional opinion on all the karyotypes.
Chromosomes were prepared using PHA stimulated lymphocyte cultures in Iscove's low folate medium. Ethidium bromide (10 ,ug/ml) was added to the cultures two hours before harvest to produce more extended chromosomes for higher resolution banding analysis. G banding was carried out using a trypsin-Giemsa method.
Results
The cytogenetic results are summarised in the Where the parents' chromosomes had been examined (patients 1, 2, 3, and 5) they did not show the same deletion.
Patient 7 did not appear to have a deletion but a pericentric inversion involving breakpoints at the The association of Angelman's syndrome with deletions within 15qll-13 short arm region i5pll and the long arm region 15q13 (fig 2) . This inversion was also present in this boy's mother; the father's chromosomes were normal. Patients 8 to 12 had no discernable abnormality.
Thus, in the representative sample of Angelman's syndrome (patients 3 to 12), 40% were deleted within 15qll-13, and an additional case had a pericentric inversion involving the same region of chromosome 15.
Discussion
Reduction in the size of the small pale band nearest to the centromere, 15q11.2, is common and the clinical significance difficult to assess. However, the six deletions described here extend to include the dark band 15q12. How frequently this latter type of deletion is seen in the general population is not known, but when in 1985 two of us (MF and MG) looked at a series of 93 patients referred consecutively for cytogenetic studies, band 15q11.2 appeared deleted in 19 cases, including patient 1 in the present study and his mother. These deletions were classified as total (that is, q12 was also missing or possibly amalgamated with the centromeric band) in one (patient 1), extensive in three (including the mother of patient 1), medium in four, and small in 11 patients.
These data, obtained well before this present study or the diagnosis of Angelman's syndrome in patient 1, point to considerable normal variation in this region of chromosome 15, although it is significant that patient 1 was the only one also to show apparent deletion of band 15q12. Thus there is still no convincing theory that explains all the cytogenetic findings, because partial trisomy and tetrasomy of 15qll-12, as well as deletions of this region, are associated with the syndrome. The sib recurrence risk in Angelman's syndrome is clearly much higher than in Prader-Willi syndrome and this raises the possibility that the inheritance in Angelman's syndrome might be a combination of simple autosomal recessive inheritance and 15qll-13 chromosomal deletions, thereby producing an overall sib recurrence risk of somewhat less than 25%. Two observations from the present pilot study must be borne in mind when considering the type of inheritance.
First, if one accepts that the pericentric inversion involving 15q13 in patient 7 is causally related to Angelman's syndrome, then any hypothesis has to explain the fact that his mother appears to have exactly the same inversion but does not have the disease. Secondly, patient 9, who has a sib with definite Angelman's syndrome, and patient 8, who has a possibly affected sib, do not have visible deletions or chromosomal rearrangements. The most likely explanation for patient 9 is that he is homozygous for a recessively inherited mutation and his parents are asymptomatic carriers who face a 1 in 4 recurrence risk. On this line of reasoning it is possible that the pericentric inversion in patient 7 and his mother acts as a comparable recessively inherited mutation (perhaps resulting in down regulation of transcription of the relevant gene), but patient 7 also inherited a recessively inherited mutation from his father who just happened to be a carrier.
When it comes to large, cytogenetically detectable, de novo deletions of 15qll-13 there are two possible mechanisms. Either they combine with a mutation on the normal looking chromosome 15, that is, these patients represent unmasked heterozygotes, or the total deletion of the Angelman gene locus (loci) on a single chromsome 15 is sufficient to produce the disease. Both these situations would produce a low recurrence risk. The unmasked heterozygote hypothesis predicts a remarkably high frequency of 15q deletions in healthy people, and the latter explanation, or some variation of it, seems more likely. One such variation is that we are dealing with a duplicated gene locus in normal people, akin to the two a globin genes on each chromosome 16, and, just like a thalassaemia, significant mutations may involve just one or both chromosomes of the pair.'9
Angelman's syndrome may arise when two of the four genes are defective. A large visible deletion could eliminate both genes on the same chromosome 15 and represent a dominant new mutation with a low recurrence risk. Alternatively, a submicroscopic mutation affecting just one of the two genes on chromosome 15 could have been inherited from both parents giving the same phenotypic effect but an autosomal recessive pattern of inheritance. Fig 3  summarises our current hypothesis on the inheritance, but more research is required before firm genetic advice can be given.
Whatever is eventually shown to be the true explanation, it seems that there is a high rate of chromosomal mutation within 15qll-13. There is considerable 'normal' variation observed in 15q1.2, a significant excess of translocation breakpoints within this region,20 and cloning instability of DNA segments from the 15qll-13 region. 
